Skip to content

Magnetic stimulation in the treatment of gambling disorder

Magnetic stimulation in the treatment of gambling disorder - Magnetic stimulation in the treatment of gambling disorder (MaGa)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON58266
Enrollment
72
Registered
2025-07-14
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gambling disorder Gambling disorder

Interventions

Five days of treatment with iTBS, consisting of 50 sessions
10 sessions per day with 50 minutes between-session intervals. iTBS at 90% of the corrected resting motor threshold will be applied to the region in the left DLPFC showing the strongest anticorrelatio

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Moderate to severe gambling disorder (>5 DMS-5 criteria)A wish to stop gamblingAt least one failed treatment attempt

Exclusion criteria

Exclusion criteria: Psychiatric comorbidity that interferes with treatment, e.g. psychosis, acute suicidality, intellectual disability, cognitive disordersTMS contraindications, e.g. seizure disorders or epilepsy, serious head trauma or brain surgery, large or ferromagnetic parts in the head (except dental wire), implanted neurostimulator, pregnancyImplanted metal objects (MRI contraindication)Previous treatment with rTMS

Design outcomes

Primary

MeasureTime frame
The primary endpoint is severity of gambling behaviour after assessed by change in G-SAS score. Other endpoints include mood, gambling-related self-efficacy, behavioural impulsivity, risky decision making, and quality of life.

Secondary

MeasureTime frame
Secondary endpoints include mood, gambling-related self-efficacy, behavioural impulsivity, risky decision making, and quality of life.

Countries

Netherlands

Contacts

Public ContactA.I. Dalhuisen

Radboud Universitair Medisch Centrum

iris.dalhuisen@radboudumc.nl0650098382

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jul 3, 2026